Clinical Oral Investigations200812:168

DOI: 10.1007/s00784-007-0168-2

Recommendations for conducting controlled clinical studies of dental restorative materials

R. Hickel , J.-F. Roulet2, S. Bayne3, S. D. Heintze2, I. A. Mjör4, M. Peters3, V. Rousson5, R. Randall6, G. Schmalz7, M. Tyas8 and G. Vanherle9
(1)
Department of Operative Dentistry and Periodontology, University of Munich, Goethestraße 70, 80336 Munich, Germany
(2)
Ivoclar-Vivadent AG, Schaan, Liechtenstein
(3)
Department of Cariology, Restorative Sciences, and Endodontics, School of Dentistry, Ann Arbor, MI, USA
(4)
Department of Operative Dentistry, University of Florida, Gainesville, FL, USA
(5)
Department of Biostatistics, ISPM, University of Zurich, Zurich, Switzerland
(6)
3M ESPE Dental, St. Paul, MN, USA
(7)
Department of Operative Dentistry and Periodontology, University of Regensburg, Regensburg, Germany
(8)
School of Dental Science, University of Melbourne, Melbourne, Australia
(9)
Department of Operative Dentistry and Dental Materials, Catholic University Leuven, Leuven, Belgium
 
Published online: 12 February 2008
© Springer-Verlag 2007
Without Abstract

Erratum to: Clin Oral Invest (2007) DOI 10.1007/s00784-006-0095-7

The conflict of interest statement was missing from the original publication.

Conflict of interest statement

All authors declare that they have no conflict of interest. Prof. J.-F. Roulet is Director of R&D clinical; Dr. S. Heintze is Head of the in vitro Laboratory; Ivoclar Vivadent, Bendererstr. 2 Fl-9494 Schaan. Dr. R. Randall is Technical Manager of 3MESPE Dental, St. Paul, MN, USA. By publication they DO NOT have any benefits or other advantages.